G. E. Moore

1.2k total citations
51 papers, 882 citations indexed

About

G. E. Moore is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, G. E. Moore has authored 51 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Oncology and 13 papers in Immunology. Recurrent topics in G. E. Moore's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Glycosylation and Glycoproteins Research (6 papers) and Immunotherapy and Immune Responses (6 papers). G. E. Moore is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Glycosylation and Glycoproteins Research (6 papers) and Immunotherapy and Immune Responses (6 papers). G. E. Moore collaborates with scholars based in United States, United Kingdom and Japan. G. E. Moore's co-authors include David Pressman, Yasuo Yagi, Laura Woods, M Takahashi, A. A. Sandberg, Jun Minowada, Ruth Frampton, Subhash Chandra, T. John Martin and J. M. Moseley and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

G. E. Moore

47 papers receiving 761 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. E. Moore United States 18 336 258 223 122 108 51 882
Jørgen K. Larsen Denmark 20 430 1.3× 290 1.1× 284 1.3× 144 1.2× 105 1.0× 57 1.2k
SC Peiper United States 12 480 1.4× 451 1.7× 163 0.7× 203 1.7× 91 0.8× 22 1.1k
G Corte Italy 19 328 1.0× 144 0.6× 456 2.0× 63 0.5× 71 0.7× 42 953
Gary A. Truitt United States 9 385 1.1× 416 1.6× 422 1.9× 55 0.5× 146 1.4× 15 961
S A Cannistra United States 15 405 1.2× 324 1.3× 368 1.7× 96 0.8× 107 1.0× 24 1.1k
Courtney Moulds United States 9 585 1.7× 150 0.6× 275 1.2× 176 1.4× 71 0.7× 9 1.0k
Emiel Van Roost Belgium 11 234 0.7× 383 1.5× 855 3.8× 162 1.3× 87 0.8× 14 1.3k
Dvorak Hf United States 16 511 1.5× 153 0.6× 319 1.4× 44 0.4× 42 0.4× 26 1.1k
Chang‐Jing G. Yeh France 14 247 0.7× 68 0.3× 208 0.9× 73 0.6× 54 0.5× 21 747
H Yamada Japan 16 167 0.5× 96 0.4× 277 1.2× 101 0.8× 78 0.7× 26 737

Countries citing papers authored by G. E. Moore

Since Specialization
Citations

This map shows the geographic impact of G. E. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. E. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. E. Moore more than expected).

Fields of papers citing papers by G. E. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. E. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. E. Moore. The network helps show where G. E. Moore may publish in the future.

Co-authorship network of co-authors of G. E. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of G. E. Moore. A scholar is included among the top collaborators of G. E. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. E. Moore. G. E. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Neill, Sean, et al.. (2024). Complications and putative risk factors for cecal or colonic surgery in dogs: 79 cases (2002‐2015). Journal of Small Animal Practice. 65(9). 675–681.
2.
Minowada, Jun & G. E. Moore. (2015). T-Lymphocyte Cell Lines Derived from Patients with Acute Lymphoblastic Leukemia. Proceedings of the International Symposium on Comparative Leukemia Research. 251–261.
3.
Zhou, Danyi, Néstor F. González-Cadavid, HG Ahuja, et al.. (1988). A unique pattern of proto-oncogene abnormalities in ovarian adenocarcinomas. Cancer. 62(8). 1573–1576. 64 indexed citations
4.
Srivastava, B. I. Sahai, Jun Minowada, & G. E. Moore. (1975). High Terminal Deoxynucleotidyl Transferase Activity in a New T-Cell Line (RPMI 8402) of Acute Lymphoblastic Leukemia Origin 2. JNCI Journal of the National Cancer Institute. 55(1). 11–14. 21 indexed citations
5.
Pauly, John L., et al.. (1975). Disparity of Mixed Lymphocyte Reactivity to Cultured Cells of Human T and B Lymphoid Lines<xref ref-type="fn" rid="fn2">2</xref>. JNCI Journal of the National Cancer Institute. 54(3). 557–62. 20 indexed citations
6.
Gerner, R. & G. E. Moore. (1973). Study of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with disseminated melanoma.. PubMed. 57(1). 83–4. 7 indexed citations
7.
Han, Tao, G. E. Moore, & Joseph E. Sokal. (1971). In Vitro Lymphocyte Response to Autologous Cultured Lymphoid Cells. Experimental Biology and Medicine. 136(3). 976–979. 18 indexed citations
8.
Najarian, J S, et al.. (1970). Antiserum to cultured human lymphoblasts: preparation, purification and immunosuppressive properties in man. Transplantation. 9(5). 508–508. 2 indexed citations
9.
Matsuoka, Yukiko, Yasuo Yagi, G. E. Moore, & David Pressman. (1969). Isolation and characterization of free gamma chain of immunoglobulin produced by an established cell line of human myeloma cell origin. I. Gamma chain in culture medium.. PubMed. 102(5). 1136–43. 17 indexed citations
10.
Moore, G. E.. (1969). IMMUNOSUPPRESSION AND CANCER. The Lancet. 293(7602). 987–987. 1 indexed citations
11.
Moore, G. E., et al.. (1969). Antibody production stimulated in vitro in Burkitt lymphoma cells. Transplantation. 7(5). 431–431. 1 indexed citations
12.
Moore, G. E.. (1968). MORTAL CLONES. The Lancet. 292(7558). 47–47. 1 indexed citations
13.
Moore, G. E., et al.. (1968). Ultrastructure of human melanoma in cell culture:Electron microscopic studies. Cancer. 21(2). 202–216. 28 indexed citations
14.
Moore, G. E., et al.. (1968). Ability of Human Hematopoietic Cell Lines to Form Colonies in Soft Agar. Experimental Biology and Medicine. 128(4). 1179–1183. 18 indexed citations
15.
Moore, G. E., Irwin D. J. Bross, Robert K. Ausman, et al.. (1968). Effects of 6-mercaptopurine (NSC-755) in 290 patients with advanced cancer. Eastern Clinical Drug Evaluation Program.. PubMed. 52(6). 655–60. 9 indexed citations
16.
Chandra, Subhash, et al.. (1968). Similarity between leukocyte cultures from cancerous and noncancerous human subjects: an electron microscopic study.. PubMed. 28(10). 1982–9. 28 indexed citations
17.
Takagi, Nobuo, et al.. (1967). Electron microscopic and cytogenetic studies of cells derived from Burkitt's lymphoma.. PubMed. 27(4). 753–9. 31 indexed citations
18.
Sandberg, A. A., Toshio Sofuni, Nobuo Takagi, & G. E. Moore. (1966). Chronology and pattern of human chromosome replication, IV. Autoradiographic studies of binucleate cells.. Proceedings of the National Academy of Sciences. 56(1). 105–110. 30 indexed citations
19.
Kondo, Tatsuhei & G. E. Moore. (1958). The limitations and adverse effects of cancer chemotherapy.. PubMed. 9. 607–11. 7 indexed citations
20.
Moore, G. E., et al.. (1953). Tobacco and intra-oral cancer.. PubMed. 685–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026